13.01.2014 19:50:00
|
Merck & Co., Inc. -- Moody's: Merck's potential business divestitures are credit negative
New York, January 13, 2014 -- Moody's Investors Service commented that Merck's announcement that it is contemplating a separation of its animal health or consumer products divisions is credit negative unless proceeds from any separations are invested back into the business, deployed for acquisitions or used to reduce debt. This is because such asset separations will reduce Merck's business diversity, earnings and cash flow.